Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

about

Investigational drugs in dry eye disease.Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders Ocular Purine Receptors as Drug Targets in the Eye.Ocular Effects of Sulfur Mustard and Therapeutic Approaches.

P2860

Q38984001-960847DE-255D-4EE9-AE37-D65771E416A5 Q41574217-CB2ADABE-3EE5-4DF6-8D56-BB36F5D8F2E2 Q41651208-EA2C6687-ADA5-4D1E-859F-B6D3525B12D8 Q47993522-CE69834C-3032-4C6A-8155-217C4CD7C4C3

P2860

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

Item

http://www.wikidata.org/entity/Q38209468

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacokinetic evaluation of ...... eatment of Sjögren's syndrome.

@en

type

Item

label

Pharmacokinetic evaluation of ...... eatment of Sjögren's syndrome.

@en

prefLabel

Pharmacokinetic evaluation of ...... eatment of Sjögren's syndrome.

@en

P1476

Pharmacokinetic evaluation of ...... eatment of Sjögren's syndrome.

@en

P2093

Dominique Bremond-Gignac

http://www.w3.org/2001/XMLSchema#string

Frédéric Chiambaretta

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Gicquel

http://www.w3.org/2001/XMLSchema#string

P2860

Topical ciclosporin in the treatment of ocular surface disorders

Treatment of ocular inflammatory conditions with loteprednol etabonate

Preservatives in eyedrops: the good, the bad and the ugly.

Sodium hyaluronate eyedrops in the treatment of dry eyes.

Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.

Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients

Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study

Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.

P304

905-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2014.915026

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24797483

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

about

P2860

P2860

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698